Biomedical subjects
M Molan
Publications and source records attributed to M Molan.
Availability humanization expert model.
AH model as a tool for estimation in the occupational health care is presented. This is an expert model connecting data from the working environment with human availability and health status data. In this paper the idea of model and its components are presented.
Event-related potentials (ERPs) and intelligence in neonatally identified 47,XXY males.
The event-related potentials (ERPs) of 18 extra X males (mean age 18.1 years) were recorded during the course of phonemic and orthographic discrimination tasks. The N2 and P3 latencies and amplitudes of subjects were examined in relation to their verbal and nonverbal intelligence test scores based on assessments at three ages: prior to puberty, during puberty and at sexual maturity. The results indicated that verbal abilities at most test occasions were significantly related to P3 latencies. Nonverbal abilities were largely uncorrelated with ERPs. The findings suggest that the verbal deficits of extra X males are the result of unlateralized individual differences in neural cognitive processing.
[Peritoneal splenosis. Report of a case and pathogenetic considerations].
A clinical case of splenosis recently observed in a young man subjected at the age of 8 to splenectomy for rupture of the spleen and operated at 19 for intestinal occlusion is reported. The pathogenetic aspects of the condition, characterised by the presence of nodules of splenic tissue in the abdominal cavity, are examined through a review of the literature.
[Axillary exenteration in cancer of the breast. Notes on surgical technic].
Explore the source record for details and available documents.
[ Thrombogenic risk in phlebography. Personal studies ].
Personally observed signs of venous thrombosis arising in 19 patients given ascending phlebography are described with reference to certain clinical signs and a surgical investigation.
[Telethermographic study of the syndrome of chronic venous insufficiency of the lower extremities].
Explore the source record for details and available documents.
[Multiple carcinomas of the large intestine. Personal experience].
Explore the source record for details and available documents.
[Actinomycosis of the tongue: presentation of a case and pathogenetic considerations].
Explore the source record for details and available documents.
[Immunomorphology of sensitization. XII. Immunomorphology of the lung during experimental aerogenic sensitization].
Explore the source record for details and available documents.
[Bronchopulmonary reactions to inhalating Aspergillus antigens].
Explore the source record for details and available documents.
Pulmonary nocardiosis.
Explore the source record for details and available documents.
[Hemagglutination inhibiting (HAI) antibodies against the virus of parainfluenza 3 (PI 3) in serum of horses and cattle with periodic opthalmics].
Explore the source record for details and available documents.
Experimental pulmonary aspergillosis in sensitized rabbits.
Explore the source record for details and available documents.
[Correlations between culture methods, double diffusion and immunofluorescence in the laboratory diagnosis of mycoses (candidiasis and aspergillosis)].
Of a total of 1950 patients with various pneumologic affections 115 cases were selected, on the basis of positive mycologic results on examination of the bronchial aspirate. In these patients immunodiffusion and immunofluorescence serological tests were carried out. Confrontation with the clinical and histopathologic diagnosis showed that the simultaneous use of mycological studies (of the bronchial aspirate) and of complex serologic investigations (immunodiffusion, immunofluorescence) allow to make a correcs and aspergilloses.
Aspergillary mycetomas ("aspergillomas") of the lung. Histopathologic and mycologic investigations in 45 cases.
Explore the source record for details and available documents.
[Immune reactivity and immunomodulator-induced changes in bronchopulmonary infections].
Explore the source record for details and available documents.
[Our experience with Bay-b 5097 (clotrimazole). A new antimycotic chemotherapeutic agent].
Explore the source record for details and available documents.